An increased level of fumarate can act directly on succinate kinase ZAP70 and reduce its activity in tumor-infiltrating CD8+ T cells, thereby inhibiting the activation of CD8+ T cells and the antitumor immune response, both in vitro and in vivo [60]. The gene discussed is CD8A; the disease is neoplasm.